pyrroles has been researched along with pexidartinib in 104 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 48 (46.15) | 24.3611 |
2020's | 56 (53.85) | 2.80 |
Authors | Studies |
---|---|
Antonescu, CR; Besmer, P; Cavnar, MJ; Cohen, NA; Crawley, MH; Dematteo, RP; Green, BL; Greer, JB; Kim, TS; Ku, AT; Pillarsetty, N; Popow, R; Rossi, F; Seifert, AM; Sorenson, EC; Veach, DR; Zeng, S | 1 |
Beckman, MJ; de Stanchina, E; Dematteo, RP; Patwardhan, PP; Schwartz, GK; Surriga, O; Tap, WD | 1 |
Galanis, A; Levis, M | 1 |
Bashir, A; Bollag, G; Burton, EA; Carias, H; Damon, LE; Habets, G; Hsu, HH; Ibrahim, PN; Kasarskis, A; Lasater, EA; Le, MH; Lin, KC; Massi, E; Matusow, B; Pendleton, M; Perl, A; Powell, B; Sebra, R; Shah, NP; Shellooe, R; Smith, CC; Spevak, W; Tsang, G; West, BL; Zhang, C; Zhang, J; Zhang, Y | 1 |
Arens, R; Melief, CJ; Sluijter, M; van der Burg, SH; van der Sluis, TC; van Duikeren, S; van Hall, T; West, BL | 1 |
Bollag, G; Graeber, TG; Hu-Lieskovan, S; Koya, RC; Mok, S; Ribas, A; Tsoi, J; West, BL | 1 |
Burton, EA; Chartier, S; Habets, G; Jimenez-Andrade, JM; Lin, PS; Mantyh, PW; Thompson, ML; Tsai, J; West, BL | 1 |
Arora, RP; Green, KN; Hernandez, MX; Lee, RJ; Rice, RA; Spangenberg, EE; Tenner, AJ; West, BL; Yamate-Morgan, H | 1 |
Anthony, SP; Bollag, G; Burton, EA; Chmielowski, B; Cohn, AL; Gee, C; Habets, G; Healey, JH; Hirth, P; Hsu, HH; Ibrahim, PN; Keedy, VL; Kim, MJ; Kwak, EL; Lin, PS; Marimuthu, A; Nguyen, H; Nolop, K; Peterfy, C; Puzanov, I; Ramanathan, RK; Sanftner, L; Severson, P; Shapiro, GI; Shellooe, R; Singh, AS; Staddon, AP; Tap, WD; Tong-Starksen, S; Tsang, G; van de Rijn, M; Visor, G; Von Hoff, DD; Wagner, AJ; Wainberg, ZA; Weiss, GJ; West, BL; Zhang, C; Zhang, J; Zhang, Y | 1 |
Butowski, N; Cloughesy, TF; Colman, H; De Groot, JF; Haidar, S; Hsu, HH; Huse, J; Ligon, KL; Marimuthu, A; Molinaro, AM; Nayak, L; Nolop, KB; Omuro, AM; Perry, A; Phillips, J; Prados, M; Wen, PY; West, BL | 1 |
Cunyat, F; McCune, JM; Rainho, JN; Stevenson, M; Swainson, L; West, B | 1 |
Baier, F; Bise, T; de Preux Charles, AS; Jaźwińska, A; Marro, J | 1 |
Feng, X; Gupta, N; Jopson, TD; Liu, S; Paladini, MS; Rosi, S; West, BL | 1 |
Jin, WN; Li, M; Li, Z; Liu, Q; Ren, H; Sheth, KN; Shi, FD; Wood, K | 1 |
Cuccarese, MF; Dubach, JM; Engblom, C; Garris, C; Miller, MA; Pfirschke, C; Pittet, MJ; Weissleder, R | 1 |
Gonzales, RJ; Jin, WN; Li, M; Li, Z; Liu, Q; Shi, SX; Wood, K | 1 |
Aerts, JG; Bezemer, K; Dammeijer, F; Hegmans, JP; Hendriks, RW; Kaijen-Lambers, ME; Lievense, LA; van Hall, T; van Nimwegen, M | 1 |
Cvetanovic, M; Johnson, A; Kim, JH; Lukowicz, A; Qu, W; Svedberg, D | 1 |
Ao, JY; Cai, H; Chai, ZT; Kong, LQ; Ma, DN; Sun, HC; Ye, BG; Zhang, KZ; Zhang, N; Zhang, YY; Zhu, XD | 1 |
Akkari, L; Huse, JT; Joyce, JA; Kowal, J; Schuhmacher, AJ; West, BL; Yan, D | 1 |
Li, M; Liu, Q; Ma, C; Qiu, S; Ren, H; Shi, FD; Wood, K; Yang, X | 1 |
Canter, RG; Dominique, MA; Fang, TC; Khan, T; Lee, VM; Miller, KR; Ransohoff, RM; Restrepo, CR; Roberts, CJ; Spiller, KJ; Trojanowski, JQ | 1 |
Albay, R; Baglietto-Vargas, D; Glabe, CG; LaFerla, FM; Philipp, S; Reyes-Ruiz, JM; Sosna, J | 1 |
Alifano, M; Barrin, S; Bercovici, N; Biton, J; Damotte, D; Donnadieu, E; Feuillet, V; Guérin, M; Kantari-Mimoun, C; Lemoine, J; Lupo, A; Ouakrim, H; Peranzoni, E; Régnier, F; Vimeux, L | 1 |
Alberti, L; Blay, JY; Brahmi, M; Cassier, P; Eberst, L; Karanian, M; Pissaloux, D; Tirode, F | 1 |
Grant, FM; Gyori, D; Hawkins, PT; Lim, EL; Okkenhaug, K; Roychoudhuri, R; Shuttleworth, SJ; Spensberger, D; Stephens, LR | 1 |
Hara, H; Kuse, Y; Nakamura, S; Ohuchi, K; Shimazawa, M | 1 |
Crapser, J; Green, KN; Jiang, S; Mortazavi, A; Najafi, AR; Ng, W; West, BL | 1 |
Eto, K; Kashiwagi, K; Koizumi, S; Nabekura, J; Ohno, N; Shinozaki, Y; Takeda, A; Wake, H | 1 |
Bollag, G; Guan, W; Hu, J; Tan, P; Tang, Z; West, BL; Wu, L; Xu, H; Yang, L | 1 |
Bennett, RE; Bryant, A; Hopp, SC; Hu, M; Hyman, BT; Robbins, AB | 1 |
Cheng, L; Dai, L; Deng, H; Jiang, Q; Li, J; Li, Y; Li, Z; Lin, Y; Liu, L; Liu, Y; Shi, G; Su, X; Wang, H; Wang, Q; Wei, Y; Yang, Q; Yang, S; Yang, Y; Yu, D; Zhang, H; Zhang, S; Zhang, X; Zhang, Y | 1 |
Berve, K; Groh, J; Klein, D; Martini, R; West, BL | 1 |
Luo, Q; Qian, Y; Qiao, S; Xu, G; Zhang, Z | 1 |
Barati, S; Kashani, IR; Madadi, S; Mortezaee, K; Pasbakhsh, P; Tahmasebi, F | 1 |
Amato, LB; Baldassarre, M; Bridgeman, VL; Columbaro, M; Cossarizza, A; De Luise, M; Feichtinger, RG; Foriel, S; Gasparre, G; Gibellini, L; Girolimetti, G; Grifoni, D; Iommarini, L; Kofler, B; Kurelac, I; Leone, G; Malanchi, I; Ombrato, L; Porcelli, AM; Ragazzi, M; Sollazzo, M; Umesh Ganesh, N; Vatrinet, R; Vidali, S; Vidone, M | 1 |
Chen, TW; Cheng, AL; Chiu, LL; Hsu, CH; Ishizuka, T; Lee, JH; Lin, CC; Oguma, T; Sasaki, SI; Sugihara, M; Tajima, N; Yang, JC; Yen, YH | 1 |
Hyun, H; Lyle, LT; Pang, L; Pei, Y; Uzunalli, G; Yeo, Y | 1 |
Dong, QZ; Gao, XM; Hsu, JL; Hung, MC; Jia, HL; Li, CW; Li, JH; Lim, SO; Lu, L; Luo, Q; Qin, LX; Sheng, YY; Xu, D; Yang, J; Zhang, Y; Zhang, Z; Zhao, Y; Zheng, Y; Zhu, Y | 1 |
Adams, SE; Brooks, AES; Jaiswal, JK; Jamieson, SMF; Masson, SW; Merry, TL; Shepherd, PR | 1 |
Bennett, JL; Dickson, EL; Given, KS; Liu, Y; Macklin, WB; Owens, GP | 1 |
Ge, XT; Guo, JX; Li, CL; Li, TY; Lv, F; Wang, XF; Wang, YJ | 1 |
Ducruet, AF; Lawton, MT; Qiu, S; Sheth, KN; Shi, E; Shi, K | 1 |
Jue, L; Li, X; Pang, X; Wang, S | 1 |
Adamson, T; Antonescu, CR; Chi, P; Condy, M; D'Angelo, SP; Dickson, MA; Gounder, M; Hwang, S; Kelly, C; Keohan, ML; Mcfadyen, CR; Movva, S; Qin, LX; Rosenbaum, E; Singer, S; Tap, WD | 1 |
Boussioutas, A; Brunnberg, J; Buchert, M; Dijkstra, C; Eissmann, MF; Ernst, M; Etemadi, N; Grimbaldeston, MA; Hibbs, ML; Huntington, ND; Jarnicki, A; Masson, F; O'Donoghue, RJJ; Phesse, T; Poh, AR; Thiem, S; Tsantikos, E | 1 |
Holtzman, DM; Hoyle, R; Long, J; Manis, M; Remolina Serrano, J; Shi, Y; Sullivan, PM; Wang, K | 1 |
Lamb, YN | 1 |
Bailey, NG; Brown, NA; Chowdhury, P; Dewar, H; Dewar, R; Elenitoba-Johnson, KSJ; Inamdar, K; Lim, MS; Murga-Zamalloa, C; Onder, O; Polk, A; Rolland, DCM; Wilcox, RA; Wolfe, A | 1 |
Cong, L; Dong, J; Ke, M; Li, Y; Lv, Y; Wang, X; Zhang, Z; Zhao, S; Zhu, Y | 1 |
Aplin, AE; Chervoneva, I; Erkes, DA; Field, CO; Rosenbaum, SR; Villanueva, J | 1 |
Abdel-Wahab, O; Abramson, D; Arcila, ME; Berger, MF; Ceyhan-Birsoy, O; De Munck, S; Decaux, O; Diamond, EL; Drilon, A; Dunkel, IJ; Durham, BH; Emile, JF; Erickson, C; Geissmann, F; Haroche, J; Hyman, DM; Ki, M; Lacouture, ME; Ladanyi, M; Lopez Rodrigo, E; Lu, SX; Mandelker, D; Mora, J; Pannecoucke, E; Pastore, A; Petrova-Drus, K; Picarsic, J; Rotemberg, V; Saganty, R; Santa-María López, V; Savvides, SN; Solit, DB; Ulaner, GA; Walsh, M; Yabe, M; Yoshimi, A | 1 |
Crapser, JD; Green, KN; Ochaba, J; Reidling, JC; Soni, N; Thompson, LM | 1 |
Bjelic, S; Friedman, R; Georgoulia, PS | 1 |
Cano, M; Gad, M; Green, KN; Leslie, FM; Linker, KE; Tawadrous, P; Wood, MA | 1 |
Coleman, LG; Crews, FT; Zou, J | 1 |
Brazina, S; Clark, D; Hsieh, CL; Hu, D; Marcucio, R; Miclau, T; Nakamura, MC; Niemi, EC; Yang, F | 1 |
Crosby, MR; Hudson, WA; Laoharawee, K; Largaespada, DA; Larsson, AT; Mills, LJ; Moriarity, BS; Osum, SH; Peterson, JJ; Pomeroy, EJ; Rahrmann, EP; Rathe, SK; Slipek, NJ; Smeester, BA; Stratton, N; Wang, M; Williams, KB; Yamamoto, K | 1 |
Donati, DM; Longhi, A; Palmerini, E; Staals, EL | 1 |
Bollag, G; Frankfurt, O; Hsu, HH; Kayser, S; Lam, B; Le, MH; Levis, MJ; Pagel, JM; Perl, AE; Roboz, GJ; Severson, PL; Smith, CC; Stone, RM; Wang, ES; West, BL; Zhang, C | 1 |
Cai, Z; Chen, Z; Huang, C; Lu, J; Lu, X; Tong, L; Wang, D; Ye, T; Yuan, X | 1 |
Benner, B; Carson, WE; Cherian, MA; Good, L; Kassem, M; Quiroga, D; Sardesai, S; Schultz, TE; Wesolowski, R | 1 |
Baldi, GG; Gronchi, A; Stacchiotti, S | 1 |
Jiang, Z; Shi, L; Tang, C; Xu, RA; Zhang, B | 1 |
Lazaridis, D; Monestime, S | 1 |
de Sande, MV; Gelderblom, H | 1 |
Tap, W | 1 |
Choi, HD; Choi, JY; Jeong, YJ; Lee, HJ; Nam, KR; Oh, SJ; Shin, NR; Son, Y | 1 |
Babiker, HM; Gajee, R; Gordon, MS; Greenberg, J; Kobayashi, F; Wagner, AJ; Wang, Q; Zahir, H; Zamora, C | 1 |
Barati, S; Kashani, IR; Madadi, S; Pasbakhsh, P; Tahmasebi, F | 1 |
Bartolucci, M; Cancedda, L; Catelani, T; Contestabile, A; Fumagalli, A; Morelli, G; Perlini, LE; Petretto, A; Pinto, B; Rastogi, M; Savardi, A; Varea, E | 1 |
Gelderblom, H; Healey, JH; Kang, J; Knebel, W; Shuster, D; Stacchiotti, S; Tap, WD; van de Sande, M; Wagner, AJ; Yin, O; Zahir, H | 1 |
Berve, K; Groh, J; Martini, R; West, BL | 1 |
Alsayadi, YMMA; Chawla, PA | 1 |
Alhudaithi, SS; Almuqbil, RM; Bielski, ER; Bos, PD; da Rocha, SRP; Du, W; Sunbul, FS; Zhang, H | 1 |
Bernthal, NM; Desai, J; Frezza, AM; Gelderblom, H; Healey, JH; Hsu, HH; Palmerini, E; Peterfy, CG; Shuster, DE; Staals, EL; Stacchiotti, S; Tap, WD; van de Sande, MAJ; Wagner, AJ; Wainberg, ZA; Wang, Q | 1 |
Baba, HA; Bauer, S; Choi, Y; Druta, M; Gelderblom, H; Healey, JH; Lewis, JH; Lin, CC; Pousa, AL; Shuster, DE; Stacchiotti, S; Tap, WD; van de Sande, M; Wagner, AJ; Wang, Q | 1 |
Green, KN; Holmes, TC; Liu, YJ; Spangenberg, EE; Tang, B; Xu, X | 1 |
Hong, JS; Hou, L; Jing, L; Li, S; Peng, B; Ruan, Z; Wang, Q; Zhang, D; Zhang, X; Zhao, J | 1 |
Drogaris, L; Henderson, M; Islam, Z; Julian, M; O'Donnell, N; Salas, M; Stemhagen, A; Tu, N | 1 |
Boehm-Sturm, P; Brandenburg, S; Heinz, R; Kremenetskaia, I; Nieminen-Kelhä, M; Schneider, UC; Vajkoczy, P | 1 |
Boyd, MM; Collier, LS; Hagemann, TL; Litscher, SJ; Messing, A; Seitz, LL | 1 |
Miyata, M; Ueta, Y | 1 |
Arenas, F; Balagué, O; Campo, E; Capdevila, C; Carreras, J; Cid, MC; Colomer, D; Guerrero-Hernández, M; Hernández, L; López-Guillermo, A; Magnano, L; Martin, S; Matas-Céspedes, A; Pérez-Galán, P; Rivas-Delgado, A; Rodriguez, V; Serrat, N; Tannheimer, S; Valero, JG; Yahiaoui, A | 1 |
Alcindor, T; Desai, J; Ganjoo, K; Gelderblom, H; Gelhorn, HL; Healey, JH; Martín-Broto, J; Palmerini, E; Shuster, D; Speck, RM; Stacchiotti, S; Tap, WD; Van De Sande, M; Wagner, AJ; Wang, Q; Ye, X | 1 |
Barati, S; Kashani, IR; Tahmasebi, F | 1 |
Ci, L; Dong, H; Fei, J; Huang, F; Li, Q; Liu, Z; Ma, Y; Shen, C; Shen, R; Sun, R; Wang, J; Wang, Z; Yu, M; Zhang, X | 1 |
Chen, A; Hirbe, AC; Lee, SM; Manji, GA; Pellicciotta, I; Pradhan, J; Rabadan, R; Raufi, AG; Schwartz, GK; Van Tine, BA | 1 |
Shen, Q; Zhang, G | 1 |
da Silva, AM; da Silva, MCM; de Barros Fernandes, H; de Miranda, AS; de Oliveira, ACP; Gomes, GF; Moreira, FA; Teixeira, AL | 1 |
Baczynska, E; Baidoe-Ansah, D; Cangalaya, C; Dityatev, A; Kaushik, R; Strackeljan, L; Wlodarczyk, J | 1 |
Almonte, VM; Egaña-Gorroño, L; Jayakumar, S; Oliveira-Paula, GH; Parikh, D; Riascos-Bernal, DF; Sibinga, NES; Uriyanghai, U; Zhang, J | 1 |
French, J; Gelderblom, H; Greenberg, J; Healey, JH; Polhamus, D; Shuster, D; Stacchiotti, S; Tap, WD; van de Sande, M; Wagner, AJ; Wang, X; Yin, O; Zahir, H | 1 |
Beckett, B; Hansford, B; Helming, A | 1 |
Chen, Y; Gao, M; Guo, Y; Jiang, M; Li, T; Liu, H; Qu, Y; Sun, X; Wan, X; Wang, F; Wang, Y; Zhao, X | 1 |
Anthony, SP; Braiteh, F; Chmielowski, B; Cohn, AL; Cote, GM; Gelhorn, HL; Healey, JH; Hsu, HH; Keedy, VL; Lin, PS; Peterfy, C; Puzanov, I; Severson, P; Shapiro, GI; Sherman, E; Singh, AS; Sterba, M; Tap, WD; Tong-Starksen, S; Wagner, AJ; Wainberg, ZA; West, BL; Ye, X; Zhang, C | 1 |
Bode-Böger, SM; Feist, E; Martens-Lobenhoffer, J; Tomaras, S | 1 |
Abeykoon, JP; Bennani, NN; Dasari, S; Davidge-Pitts, CJ; Flanagan, EP; Go, RS; Goyal, G; Koster, MJ; Lasho, TL; Manske, MK; Nowakowski, KE; Patnaik, MM; Ranatunga, WK; Ravindran, A; Rech, KL; Ruan, GJ; Ryu, JH; Shah, MV; Tischer, A; Tobin, WO; Vassallo, R; Witzig, TE; Wu, X; Young, JR | 1 |
Asiri, YA; Ezzeldin, E; Iqbal, M; Mostafa, GAE; Sayed, AYA | 1 |
Gao, X; Han, Z; Lei, P; Li, M; Li, X; Liu, M; Liu, Q; Zhang, W | 1 |
Choi, Y; Dharmani, C; Diggs, A; Jiang, J; Keedy, VL; McCabe, C; Salas, M; Wang, E | 1 |
Greenberg, J; Healey, JH; Hsu, C; LaCreta, F; Lasseter, KC; Marbury, TC; Stacchiotti, S; Tap, WD; Xu, LA; Zahir, H | 1 |
Appel, D; Hummel, R; Klein, M; Li, S; Ritter, K; Schäfer, MKE; Strehle, J; Tegeder, I; Wang, Y; Wernersbach, I | 1 |
Damron, TA | 1 |
8 review(s) available for pyrroles and pexidartinib
Article | Year |
---|---|
Pexidartinib: First Approval.
Topics: Aminopyridines; Antineoplastic Agents; Drug Approval; fms-Like Tyrosine Kinase 3; Giant Cell Tumor of Tendon Sheath; Humans; Macrophage Colony-Stimulating Factor; Protein Kinase Inhibitors; Proto-Oncogene Mas; Proto-Oncogene Proteins c-kit; Pyrroles; United States; United States Food and Drug Administration | 2019 |
Pexidartinib for the treatment of adult patients with symptomatic tenosynovial giant cell tumor: safety and efficacy.
Topics: Adult; Aminopyridines; Antineoplastic Agents; Chemical and Drug Induced Liver Injury; Giant Cell Tumor of Tendon Sheath; Humans; Macrophage Colony-Stimulating Factor; Neoplasm Recurrence, Local; Pyrroles; Quality of Life | 2020 |
Pexidartinib, a Novel Small Molecule CSF-1R Inhibitor in Use for Tenosynovial Giant Cell Tumor: A Systematic Review of Pre-Clinical and Clinical Development.
Topics: Aminopyridines; Antineoplastic Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug; Giant Cell Tumor of Tendon Sheath; Humans; Molecular Structure; Pyrroles; Receptors, Granulocyte-Macrophage Colony-Stimulating Factor; Structure-Activity Relationship | 2020 |
Pexidartinib for the treatment of adult symptomatic patients with tenosynovial giant cell tumors.
Topics: Adult; Aminopyridines; Antineoplastic Agents; Giant Cell Tumor of Tendon Sheath; Humans; Macrophage Colony-Stimulating Factor; Neoplasm Recurrence, Local; Pyrroles; Quality of Life; Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 2020 |
Pexidartinib (TURALIO™): The First FDA-Indicated Systemic Treatment for Tenosynovial Giant Cell Tumor.
Topics: Administration, Oral; Adult; Aminopyridines; Antineoplastic Agents; Clinical Trials as Topic; Contraindications, Drug; Drug Approval; Drug Interactions; Female; Giant Cell Tumor of Tendon Sheath; Humans; Macrophage Colony-Stimulating Factor; Male; Middle Aged; Protein Kinase Inhibitors; Pyrroles; United States; United States Food and Drug Administration | 2020 |
Pexidartinib: first approved systemic therapy for patients with tenosynovial giant cell tumor.
Topics: Aminopyridines; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Diagnostic Imaging; Disease Management; Giant Cell Tumor of Tendon Sheath; Humans; Molecular Targeted Therapy; Neoplasm Staging; Protein Kinase Inhibitors; Pyrroles; Receptors, Granulocyte-Macrophage Colony-Stimulating Factor; Structure-Activity Relationship; Treatment Outcome | 2020 |
Prospects of Treating Tenosynovial Giant Cell Tumor through Pexidartinib: A Review.
Topics: Aminopyridines; Antineoplastic Agents; Giant Cell Tumor of Tendon Sheath; Humans; Macrophage Colony-Stimulating Factor; Pyrroles; Receptor, Macrophage Colony-Stimulating Factor; United States; United States Food and Drug Administration | 2021 |
Turalio risk evaluation and mitigation strategy for treatment of tenosynovial giant cell tumor: framework and experience.
Topics: Adult; Aminopyridines; Giant Cell Tumor of Tendon Sheath; Humans; Pyrroles; Risk Evaluation and Mitigation; United States; United States Food and Drug Administration | 2022 |
8 trial(s) available for pyrroles and pexidartinib
Article | Year |
---|---|
Structure-Guided Blockade of CSF1R Kinase in Tenosynovial Giant-Cell Tumor.
Topics: Adult; Aged; Aminopyridines; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Discovery; Female; Giant Cell Tumors; Humans; Male; Middle Aged; Pyrroles; Receptor, Macrophage Colony-Stimulating Factor; Soft Tissue Neoplasms; Tendons; Tumor Burden | 2015 |
Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study.
Topics: Administration, Oral; Aminopyridines; Biomarkers, Tumor; Blood-Brain Barrier; Brain Neoplasms; Cohort Studies; Female; Follow-Up Studies; Glioblastoma; Humans; Immunoenzyme Techniques; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Pyrroles; Receptors, Granulocyte-Macrophage Colony-Stimulating Factor; Tissue Distribution; Tumor Burden | 2016 |
A phase I study of pexidartinib, a colony-stimulating factor 1 receptor inhibitor, in Asian patients with advanced solid tumors.
Topics: Adult; Aged; Aged, 80 and over; Aminopyridines; Biomarkers, Tumor; Female; Follow-Up Studies; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neoplasms; Non-Randomized Controlled Trials as Topic; Prognosis; Pyrroles; Receptors, Granulocyte-Macrophage Colony-Stimulating Factor; Tissue Distribution; Young Adult | 2020 |
A Phase I Study of Binimetinib (MEK162) Combined with Pexidartinib (PLX3397) in Patients with Advanced Gastrointestinal Stromal Tumor.
Topics: Aged; Aminopyridines; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Synergism; Female; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Male; Maximum Tolerated Dose; Middle Aged; Pyrroles; Tissue Distribution | 2019 |
A phase 1/2 study of the oral FLT3 inhibitor pexidartinib in relapsed/refractory FLT3-ITD-mutant acute myeloid leukemia.
Topics: Aminopyridines; fms-Like Tyrosine Kinase 3; Humans; Leukemia, Myeloid, Acute; Phenylurea Compounds; Protein Kinase Inhibitors; Pyrroles | 2020 |
Evaluation of Potential Drug-Drug Interaction Risk of Pexidartinib With Substrates of Cytochrome P450 and P-Glycoprotein.
Topics: Adult; Aged; Aminopyridines; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cross-Over Studies; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP3A; Drug Interactions; Female; Humans; Male; Middle Aged; Pyrroles | 2021 |
Population Pharmacokinetic Analysis of Pexidartinib in Healthy Subjects and Patients With Tenosynovial Giant Cell Tumor or Other Solid Tumors.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Aminopyridines; Antineoplastic Agents; Area Under Curve; Asian People; Bacterial Proteins; Body Weight; Creatinine; Female; Giant Cell Tumor of Tendon Sheath; Humans; Kidney Function Tests; Liver Function Tests; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Pyrroles; Racial Groups; Sex Factors; Sociodemographic Factors; Tumor Burden; Young Adult | 2021 |
Pexidartinib improves physical functioning and stiffness in patients with tenosynovial giant cell tumor: results from the ENLIVEN randomized clinical trial.
Topics: Adult; Aminopyridines; Double-Blind Method; Female; Giant Cell Tumor of Tendon Sheath; Humans; Lower Extremity; Male; Middle Aged; Patient Reported Outcome Measures; Pyrroles | 2021 |
88 other study(ies) available for pyrroles and pexidartinib
Article | Year |
---|---|
Increased KIT inhibition enhances therapeutic efficacy in gastrointestinal stromal tumor.
Topics: Aminopyridines; Animals; Antineoplastic Agents; Benzamides; Biopsy; Cell Survival; Disease Models, Animal; Drug Evaluation, Preclinical; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Inhibitory Concentration 50; Mice, Knockout; Molecular Targeted Therapy; Piperazines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; Pyrimidines; Pyrroles; Receptor, Macrophage Colony-Stimulating Factor; Tumor Burden | 2014 |
Sustained inhibition of receptor tyrosine kinases and macrophage depletion by PLX3397 and rapamycin as a potential new approach for the treatment of MPNSTs.
Topics: Aminopyridines; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzamides; Blotting, Western; Cell Proliferation; Humans; Imatinib Mesylate; Macrophages; Mice; Mice, Inbred ICR; Mice, SCID; Neurilemmoma; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Pyrroles; Receptor, Platelet-Derived Growth Factor beta; Sirolimus; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2014 |
Inhibition of c-Kit by tyrosine kinase inhibitors.
Topics: Aminopyridines; Antineoplastic Agents; Benzothiazoles; Biomarkers; Bone Marrow; Cell Line, Tumor; Clinical Trials as Topic; Dasatinib; fms-Like Tyrosine Kinase 3; Gene Expression; Hair; Hematopoietic Stem Cells; Humans; Indazoles; Leukemia, Myeloid, Acute; Niacinamide; Phenylurea Compounds; Pigmentation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; Pyrimidines; Pyrroles; Sorafenib; Sulfonamides; Thiazoles | 2015 |
Characterizing and Overriding the Structural Mechanism of the Quizartinib-Resistant FLT3 "Gatekeeper" F691L Mutation with PLX3397.
Topics: Aminopyridines; Animals; Antineoplastic Agents; Benzothiazoles; Cell Line, Tumor; Drug Resistance, Neoplasm; Enzyme Activation; fms-Like Tyrosine Kinase 3; Heterografts; Humans; Leukemia, Myeloid, Acute; Mice; Models, Molecular; Molecular Conformation; Mutation; Phenylurea Compounds; Protein Binding; Protein Interaction Domains and Motifs; Protein Kinase Inhibitors; Pyrroles; Recurrence; Structure-Activity Relationship | 2015 |
Therapeutic Peptide Vaccine-Induced CD8 T Cells Strongly Modulate Intratumoral Macrophages Required for Tumor Regression.
Topics: Aminopyridines; Animals; Cancer Vaccines; CD8-Positive T-Lymphocytes; Cell Movement; Chemokines; Disease Models, Animal; Female; Lymphocytes, Tumor-Infiltrating; Macrophages; Mice, Inbred C57BL; Myeloid Cells; Ovarian Neoplasms; Protein-Tyrosine Kinases; Pyrroles; Vaccines, Subunit | 2015 |
Inhibition of colony stimulating factor-1 receptor improves antitumor efficacy of BRAF inhibition.
Topics: Aminopyridines; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Drug Screening Assays, Antitumor; Drug Synergism; Indoles; Lymphocyte Activation; Macrophages; Melanoma, Experimental; Mice, Inbred C57BL; Mice, Inbred NOD; Mice, SCID; Neoplasm Transplantation; Proto-Oncogene Proteins B-raf; Pyrroles; Receptor, Macrophage Colony-Stimulating Factor; Sulfonamides; T-Lymphocytes; Vemurafenib | 2015 |
Targeting cells of the myeloid lineage attenuates pain and disease progression in a prostate model of bone cancer.
Topics: Aminopyridines; Analgesics; Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Bone and Bones; Bone Neoplasms; Cell Line, Tumor; Disease Models, Animal; Disease Progression; Dogs; Formaldehyde; Male; Mice; Mice, Nude; Neoplasm Transplantation; Pain; Pain Measurement; Prostatic Neoplasms; Protein Kinases; Pyrroles; Rats; Rats, Sprague-Dawley | 2015 |
Elimination of Microglia Improves Functional Outcomes Following Extensive Neuronal Loss in the Hippocampus.
Topics: Aminopyridines; Animals; Behavioral Symptoms; Blood-Brain Barrier; Brain Injuries; Cognition Disorders; Dendritic Spines; Disease Models, Animal; Doxycycline; Female; Hippocampus; Male; Maze Learning; Mice; Mice, Transgenic; Microglia; Neurons; Phosphopyruvate Hydratase; Pyrroles; Recovery of Function; Synaptophysin | 2015 |
Colony-Stimulating Factor 1 Receptor Antagonists Sensitize Human Immunodeficiency Virus Type 1-Infected Macrophages to TRAIL-Mediated Killing.
Topics: Aminopyridines; CD4-Positive T-Lymphocytes; Cells, Cultured; HIV Infections; HIV-1; Humans; Macrophage Colony-Stimulating Factor; Macrophages; Pyrroles; Receptor, Macrophage Colony-Stimulating Factor; TNF-Related Apoptosis-Inducing Ligand; Virus Latency; Virus Replication | 2016 |
Distinct effects of inflammation on preconditioning and regeneration of the adult zebrafish heart.
Topics: Aminopyridines; Animals; Anti-Inflammatory Agents; Cell Cycle; Cell Proliferation; Cryopreservation; Disease Models, Animal; Heart; Inflammation; Ischemic Preconditioning, Myocardial; Leukocytes; Myocardial Infarction; Myocytes, Cardiac; Pyrroles; Regeneration; Thoracotomy; Zebrafish | 2016 |
Colony-stimulating factor 1 receptor blockade prevents fractionated whole-brain irradiation-induced memory deficits.
Topics: Aminopyridines; Animals; Brain; Male; Memory Disorders; Mice; Mice, Inbred C57BL; Mice, Transgenic; Pyrroles; Radiation Effects; Receptor, Macrophage Colony-Stimulating Factor | 2016 |
Colony stimulating factor 1 receptor inhibition eliminates microglia and attenuates brain injury after intracerebral hemorrhage.
Topics: Aminopyridines; Animals; Brain; Brain Edema; Cerebral Hemorrhage; Cytokines; Disease Models, Animal; Humans; Mice; Mice, Inbred C57BL; Microglia; Neuroimaging; Pyrroles; Receptor, Macrophage Colony-Stimulating Factor; Species Specificity | 2017 |
Heterogeneity of macrophage infiltration and therapeutic response in lung carcinoma revealed by 3D organ imaging.
Topics: Aminopyridines; Animals; Antineoplastic Agents; Carcinoma, Lewis Lung; Cell Line, Tumor; Female; Humans; Imaging, Three-Dimensional; Lung; Lung Neoplasms; Macrophage Colony-Stimulating Factor; Macrophages; Mice; Mice, Inbred C57BL; Microscopy, Confocal; Microscopy, Fluorescence; Nanoparticles; Perfusion; Pyrroles; RAW 264.7 Cells; Receptors, Granulocyte-Macrophage Colony-Stimulating Factor; Signal Transduction; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2017 |
Depletion of microglia exacerbates postischemic inflammation and brain injury.
Topics: Aminopyridines; Animals; Brain Ischemia; Cells, Cultured; Disease Models, Animal; Inflammation Mediators; Magnetic Resonance Imaging; Male; Mice, Inbred C57BL; Microglia; Neurons; Primary Cell Culture; Proto-Oncogene Proteins c-kit; Pyrroles; Reactive Oxygen Species; Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 2017 |
Depletion of Tumor-Associated Macrophages with a CSF-1R Kinase Inhibitor Enhances Antitumor Immunity and Survival Induced by DC Immunotherapy.
Topics: Aminopyridines; Animals; Antigens, Neoplasm; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Dendritic Cells; Disease Models, Animal; Humans; Immunotherapy, Adoptive; Lung Neoplasms; Macrophages; Mesothelioma; Mesothelioma, Malignant; Neoplasm Invasiveness; Programmed Cell Death 1 Receptor; Protein Kinase Inhibitors; Pyrroles; Receptor, Macrophage Colony-Stimulating Factor | 2017 |
Inhibition of colony-stimulating factor 1 receptor early in disease ameliorates motor deficits in SCA1 mice.
Topics: Aminopyridines; Animals; Ataxin-1; Calcium-Binding Proteins; Cerebellum; Disks Large Homolog 4 Protein; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Macrophage Colony-Stimulating Factor; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microfilament Proteins; Motor Activity; Motor Disorders; Mutation; Neuroglia; Postural Balance; Pyrroles; Spinocerebellar Ataxias; Tumor Necrosis Factor-alpha; Vesicular Glutamate Transport Protein 2 | 2017 |
Colony-Stimulating Factor 1 Receptor Blockade Inhibits Tumor Growth by Altering the Polarization of Tumor-Associated Macrophages in Hepatocellular Carcinoma.
Topics: Aminopyridines; Animals; Biomarkers, Tumor; Bone Marrow Cells; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Polarity; Cell Proliferation; Humans; Liver Neoplasms; Macrophage Colony-Stimulating Factor; Macrophages; Male; Mice, Inbred BALB C; Mice, Inbred C57BL; Models, Biological; Monocytes; Phenotype; Pyrroles; Receptor, Macrophage Colony-Stimulating Factor; Tumor Microenvironment | 2017 |
Inhibition of colony stimulating factor-1 receptor abrogates microenvironment-mediated therapeutic resistance in gliomas.
Topics: Aminopyridines; Animals; Becaplermin; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Drug Resistance, Neoplasm; Glioma; Humans; Mice; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-sis; Pyrroles; Receptors, Granulocyte-Macrophage Colony-Stimulating Factor; Tumor Microenvironment | 2017 |
Depletion of microglia augments the dopaminergic neurotoxicity of MPTP.
Topics: Aminopyridines; Animals; Dopaminergic Neurons; Inflammation Mediators; Leukocytes; Male; Mice; Mice, Knockout; Microglia; MPTP Poisoning; Pyrroles; Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 2018 |
Microglia-mediated recovery from ALS-relevant motor neuron degeneration in a mouse model of TDP-43 proteinopathy.
Topics: Aminopyridines; Amyotrophic Lateral Sclerosis; Animals; Gene Expression Profiling; Gliosis; Humans; Inflammation; Mice; Mice, Transgenic; Motor Neurons; Muscle, Skeletal; Mutation; Myeloid Cells; Pyrroles; Recovery of Function; Spinal Cord; Superoxide Dismutase-1; TDP-43 Proteinopathies | 2018 |
Early long-term administration of the CSF1R inhibitor PLX3397 ablates microglia and reduces accumulation of intraneuronal amyloid, neuritic plaque deposition and pre-fibrillar oligomers in 5XFAD mouse model of Alzheimer's disease.
Topics: Alzheimer Disease; Aminopyridines; Amyloidogenic Proteins; Animals; Brain; Disease Models, Animal; Mice; Mice, Transgenic; Microglia; Neurons; Plaque, Amyloid; Pyrroles; Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 2018 |
Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti-PD-1 treatment.
Topics: Aminopyridines; Animals; Carcinoma, Squamous Cell; CD8-Positive T-Lymphocytes; Follow-Up Studies; Macrophages; Mice; Programmed Cell Death 1 Receptor; Pyrroles; Receptor, Macrophage Colony-Stimulating Factor; Retrospective Studies; Xenograft Model Antitumor Assays | 2018 |
Complete response to CSF1R inhibitor in a translocation variant of teno-synovial giant cell tumor without genomic alteration of the CSF1 gene.
Topics: Aminopyridines; Female; Giant Cell Tumors; Humans; Macrophage Colony-Stimulating Factor; Middle Aged; Prognosis; Pyrroles; Receptors, Granulocyte-Macrophage Colony-Stimulating Factor; Remission Induction; Synovial Membrane; Translocation, Genetic | 2018 |
Compensation between CSF1R+ macrophages and Foxp3+ Treg cells drives resistance to tumor immunotherapy.
Topics: Aminopyridines; Animals; Cell Line, Tumor; Class I Phosphatidylinositol 3-Kinases; Diphtheria Toxin; Disease Models, Animal; Drug Resistance, Neoplasm; Female; Forkhead Transcription Factors; Gene Knockout Techniques; Humans; Lymphocyte Depletion; Macrophages; Male; Mice; Mice, Transgenic; Neoplasms; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Primary Cell Culture; Purines; Pyrroles; Quinazolinones; Receptors, Granulocyte-Macrophage Colony-Stimulating Factor; T-Lymphocytes, Regulatory; Tumor Microenvironment | 2018 |
Microglia increases the proliferation of retinal precursor cells during postnatal development.
Topics: Aminopyridines; Animals; Animals, Newborn; Bromodeoxyuridine; Calbindins; Calcium-Binding Proteins; Cell Communication; Cell Proliferation; Gene Expression Regulation, Developmental; Granulins; Injections, Intraperitoneal; Intercellular Signaling Peptides and Proteins; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Microfilament Proteins; Microglia; Nestin; Organogenesis; PAX6 Transcription Factor; Progranulins; Pyrroles; Retina; Rhodopsin; Stem Cells | 2018 |
A limited capacity for microglial repopulation in the adult brain.
Topics: Aminopyridines; Animals; Brain; Calcium-Binding Proteins; CX3C Chemokine Receptor 1; Cytokines; Dose-Response Relationship, Drug; Gene Expression Profiling; Gene Ontology; Glial Fibrillary Acidic Protein; Luminescent Proteins; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microfilament Proteins; Microglia; Pyrroles; Receptor, Platelet-Derived Growth Factor alpha; Receptors, Granulocyte-Macrophage Colony-Stimulating Factor; Signal Transduction | 2018 |
Microglia mediate non-cell-autonomous cell death of retinal ganglion cells.
Topics: Aminopyridines; Animals; Animals, Newborn; Calcium-Binding Proteins; Cell Death; Cells, Cultured; Cytokines; Excitatory Amino Acid Agonists; Gene Expression Regulation; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microfilament Proteins; Microglia; N-Methylaspartate; Nerve Degeneration; Optic Nerve Injuries; Organic Chemicals; Pyrroles; Retinal Ganglion Cells; Signal Transduction; Transcription Factor Brn-3A; Tumor Necrosis Factor-alpha | 2018 |
Inhibition of TAMs improves the response to docetaxel in castration-resistant prostate cancer.
Topics: Aminopyridines; Animals; Antineoplastic Agents; Cell Line; Cytokines; Docetaxel; Humans; Macrophages; Male; Mice; Prostatic Neoplasms, Castration-Resistant; Pyrroles; Receptor, Macrophage Colony-Stimulating Factor | 2019 |
Partial reduction of microglia does not affect tau pathology in aged mice.
Topics: Aging; Aminopyridines; Animals; Blood Vessels; Calcium-Binding Proteins; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cytokines; Disease Models, Animal; Gene Expression Regulation; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microfilament Proteins; Microglia; Mutation; Pyrroles; Receptors, Granulocyte-Macrophage Colony-Stimulating Factor; RNA, Messenger; tau Proteins; Tauopathies | 2018 |
Modulating the Tumor Microenvironment via Oncolytic Viruses and CSF-1R Inhibition Synergistically Enhances Anti-PD-1 Immunotherapy.
Topics: Aminopyridines; Animals; B7-H1 Antigen; CD8-Positive T-Lymphocytes; Colonic Neoplasms; Female; Flow Cytometry; Humans; Immunotherapy; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Oncolytic Viruses; Programmed Cell Death 1 Receptor; Pyrroles; Receptor, Macrophage Colony-Stimulating Factor; Tumor Microenvironment | 2019 |
Targeting microglia attenuates neuroinflammation-related neural damage in mice carrying human PLP1 mutations.
Topics: Aminopyridines; Animals; Anti-Inflammatory Agents; Central Nervous System Diseases; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Flow Cytometry; Humans; Inflammation; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microglia; Microscopy, Electron, Transmission; Mutation; Myelin Proteolipid Protein; Neurons; Pyrroles; T-Lymphocytes; Tomography, Optical Coherence | 2019 |
Long-term characterization of activated microglia/macrophages facilitating the development of experimental brain metastasis through intravital microscopic imaging.
Topics: Aminopyridines; Animals; Brain; Brain Neoplasms; Cell Line, Tumor; CX3C Chemokine Receptor 1; Disease Models, Animal; Functional Laterality; Gene Expression Regulation, Neoplastic; Green Fluorescent Proteins; Intravital Microscopy; Macrophages; Matrix Metalloproteinase 3; Melanoma; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microglia; Pyrroles; Time Factors; Zonula Occludens-1 Protein | 2019 |
Effect of the CSF1R inhibitor PLX3397 on remyelination of corpus callosum in a cuprizone-induced demyelination mouse model.
Topics: Aminopyridines; Animals; Corpus Callosum; Cuprizone; Demyelinating Diseases; Disease Models, Animal; Gene Expression Regulation; Indoles; Macrophage Colony-Stimulating Factor; Male; Mice, Inbred C57BL; Microglia; Microscopy, Electron, Transmission; Multiple Sclerosis; Myelin Sheath; Pyrroles; Real-Time Polymerase Chain Reaction; Receptors, Granulocyte-Macrophage Colony-Stimulating Factor; Rotarod Performance Test | 2019 |
Inducing cancer indolence by targeting mitochondrial Complex I is potentiated by blocking macrophage-mediated adaptive responses.
Topics: Adenoma, Oxyphilic; Aminopyridines; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Drosophila; Electron Transport Complex I; Female; Gene Knockout Techniques; HCT116 Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Macrophages; Metformin; Mice; Mice, Knockout; Mice, Nude; NADH Dehydrogenase; Neovascularization, Pathologic; Pyrroles; Xenograft Model Antitumor Assays | 2019 |
Surface Modification of Polymeric Nanoparticles with M2pep Peptide for Drug Delivery to Tumor-Associated Macrophages.
Topics: Aminopyridines; Animals; Cell Line; Cell Line, Tumor; Drug Carriers; Drug Delivery Systems; Humans; Macrophages; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Nanoparticles; Peptides; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Pyrroles; RAW 264.7 Cells | 2019 |
Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockade.
Topics: Aminopyridines; Animals; Antineoplastic Combined Chemotherapy Protocols; B7-H1 Antigen; Biomarkers, Tumor; Carcinoma, Hepatocellular; Chemotaxis; Cytokines; Gene Deletion; Humans; Liver Neoplasms; Lymphocytes, Tumor-Infiltrating; Macrophage Colony-Stimulating Factor; Macrophages; Male; Mice, Knockout; Molecular Targeted Therapy; Osteopontin; Prognosis; Pyrroles; Tumor Cells, Cultured; Tumor Escape; Tumor Microenvironment | 2019 |
The CSF1 receptor inhibitor pexidartinib (PLX3397) reduces tissue macrophage levels without affecting glucose homeostasis in mice.
Topics: Adipose Tissue; Aminopyridines; Animals; Diet, High-Fat; Glucose; Homeostasis; Insulin Resistance; Macrophages; Mice; Obesity; Pyrroles; Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 2020 |
Concentration-dependent effects of CSF1R inhibitors on oligodendrocyte progenitor cells ex vivo and in vivo.
Topics: Aminopyridines; Animals; Brain; Mice; Microglia; Oligodendrocyte Precursor Cells; Organic Chemicals; Pyrroles; Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 2019 |
Colony-stimulating factor 1 receptor inhibition prevents against lipopolysaccharide -induced osteoporosis by inhibiting osteoclast formation.
Topics: Aminopyridines; Animals; Biomechanical Phenomena; Bone Density; Bone Resorption; Cancellous Bone; Disease Models, Animal; Lipopolysaccharides; Male; Osteoclasts; Osteoporosis; Pyrroles; Rats, Sprague-Dawley; Receptor, Macrophage Colony-Stimulating Factor; Tibia | 2019 |
Chronic inflammation, cognitive impairment, and distal brain region alteration following intracerebral hemorrhage.
Topics: Aminopyridines; Animals; Brain; Cerebral Hemorrhage; Cognition; Cognitive Dysfunction; Disease Models, Animal; Fingolimod Hydrochloride; Flow Cytometry; Hippocampus; Inflammation; Male; Mice; Mice, Inbred C57BL; Microglia; Neuroimaging; Neuronal Plasticity; Pyrroles; Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 2019 |
[Pexidartinib inhibits the aggregation of monocytes into tumor microenvironment and reduces the number of M2 tumor-associated macrophages].
Topics: Aminopyridines; Animals; Cell Line, Tumor; Colonic Neoplasms; Flow Cytometry; Leukocytes, Mononuclear; Macrophages; Mice; Monocytes; Pyrroles; Tumor Microenvironment | 2019 |
IL-33-mediated mast cell activation promotes gastric cancer through macrophage mobilization.
Topics: Aminopyridines; Animals; Cell Degranulation; Cromolyn Sodium; Disease Models, Animal; Epithelium; Female; Gastric Mucosa; Humans; Interleukin-1 Receptor-Like 1 Protein; Interleukin-33; Macrophages; Male; Mast Cells; Mice; Mice, Transgenic; Pyrroles; Signal Transduction; Stomach Neoplasms; Tissue Array Analysis; Tumor Microenvironment | 2019 |
Microglia drive APOE-dependent neurodegeneration in a tauopathy mouse model.
Topics: Alzheimer Disease; Aminopyridines; Animals; Apolipoproteins E; Brain; Dietary Supplements; Disease Models, Animal; Humans; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Microglia; Neurodegenerative Diseases; Pyrroles; tau Proteins; Tauopathies | 2019 |
Colony-Stimulating Factor 1 Receptor (CSF1R) Activates AKT/mTOR Signaling and Promotes T-Cell Lymphoma Viability.
Topics: Aminopyridines; Animals; Cell Line, Tumor; Gene Expression Profiling; Humans; Lymphoma, T-Cell, Peripheral; Macrophage Colony-Stimulating Factor; Macrophages; Mice; Mice, Inbred NOD; Mice, SCID; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyrroles; Receptors, Granulocyte-Macrophage Colony-Stimulating Factor; Signal Transduction; TOR Serine-Threonine Kinases; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2020 |
MicroRNA-148b-colony-stimulating factor-1 signaling-induced tumor-associated macrophage infiltration promotes hepatocellular carcinoma metastasis.
Topics: Aminopyridines; Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Macrophage Colony-Stimulating Factor; Macrophages; Male; Mice; Mice, Nude; MicroRNAs; Neoplasm Metastasis; Neoplasms, Experimental; Pyrroles; Signal Transduction | 2019 |
PLX3397 inhibits the accumulation of intra-tumoral macrophages and improves bromodomain and extra-terminal inhibitor efficacy in melanoma.
Topics: Aminopyridines; Animals; Cell Line, Tumor; Cell Proliferation; Macrophages; Male; Melanoma; Mice, Inbred C57BL; Proteins; Proto-Oncogene Proteins B-raf; Pyrroles; Receptors, Granulocyte-Macrophage Colony-Stimulating Factor; Skin Neoplasms; Treatment Outcome | 2020 |
Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms.
Topics: Adolescent; Adult; Aminopyridines; Anaplastic Lymphoma Kinase; Benzothiazoles; Child; Child, Preschool; Exome Sequencing; Female; Genome, Human; Hematologic Neoplasms; Histiocytosis; Humans; Infant; Male; Mutation; Picolinic Acids; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-ret; Pyrazoles; Pyridines; Pyrroles; Receptor Protein-Tyrosine Kinases; Receptors, Granulocyte-Macrophage Colony-Stimulating Factor; Twins, Monozygotic; Young Adult | 2019 |
Microglial depletion prevents extracellular matrix changes and striatal volume reduction in a model of Huntington's disease.
Topics: Aminopyridines; Animals; Astrocytes; Chondroitin Sulfate Proteoglycans; Cytokines; Disease Models, Animal; Down-Regulation; Extracellular Matrix; Hand Strength; Humans; Huntingtin Protein; Huntington Disease; Inflammation; Mice; Mice, Transgenic; Microglia; Neostriatum; Neurites; Pyrroles; Receptors, Granulocyte-Macrophage Colony-Stimulating Factor; Recognition, Psychology; RNA, Messenger; Synapses; Transcriptome | 2020 |
Deciphering the molecular mechanism of FLT3 resistance mutations.
Topics: Aminopyridines; Benzothiazoles; Drug Resistance, Neoplasm; fms-Like Tyrosine Kinase 3; Humans; Mutation; Neoplasms; Phenylurea Compounds; Protein Conformation; Protein Kinase Inhibitors; Pyrroles | 2020 |
Microglial activation increases cocaine self-administration following adolescent nicotine exposure.
Topics: Aminopyridines; Animals; Chemokine CX3CL1; Cocaine; Disease Models, Animal; Drug-Seeking Behavior; Electronic Nicotine Delivery Systems; Female; Gene Expression Regulation; Male; Microglia; Minocycline; Nicotine; Phenotype; Pyrroles; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Reinforcement, Psychology; Reward; Self Administration; Synaptophysin | 2020 |
Microglial depletion and repopulation in brain slice culture normalizes sensitized proinflammatory signaling.
Topics: Aminopyridines; Animals; Ethanol; Hippocampus; Inflammation; Microglia; Neural Stem Cells; Organ Culture Techniques; Pyrroles; Rats; Signal Transduction; Toll-Like Receptors | 2020 |
Age-related changes to macrophages are detrimental to fracture healing in mice.
Topics: Age Factors; Aminopyridines; Animals; Bony Callus; Cellular Senescence; Fracture Healing; Fractures, Bone; Inflammation; Macrophages; Mice; Mice, Inbred C57BL; Models, Animal; Pyrroles; RNA-Seq; Tibia; Transcriptome | 2020 |
PLX3397 treatment inhibits constitutive CSF1R-induced oncogenic ERK signaling, reduces tumor growth, and metastatic burden in osteosarcoma.
Topics: Aminopyridines; Animals; Carcinogenesis; Macrophage Colony-Stimulating Factor; Mice; Osteosarcoma; Pyrroles; Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 2020 |
Antidepressive properties of macrophage-colony stimulating factor in a mouse model of depression induced by chronic unpredictable stress.
Topics: Aminopyridines; Animals; Antidepressive Agents; Depression; Dose-Response Relationship, Drug; Hippocampus; Macrophage Activation; Macrophage Colony-Stimulating Factor; Male; Mice; Mice, Inbred C57BL; Microglia; Minocycline; Pyrroles; Stress, Psychological | 2020 |
Development of UPLC-MS/MS method for studying the pharmacokinetic interactions of pexidartinib with antifungal drugs in rats.
Topics: Adult; Aminopyridines; Animals; Antifungal Agents; Chromatography, High Pressure Liquid; Chromatography, Liquid; Humans; Pharmaceutical Preparations; Pyrroles; Rats; Reproducibility of Results; Tandem Mass Spectrometry | 2020 |
ENLIVEN study: Pexidartinib for tenosynovial giant cell tumor (TGCT).
Topics: Aminopyridines; Giant Cell Tumor of Tendon Sheath; Humans; Protein Kinase Inhibitors; Pyrroles; Synovitis, Pigmented Villonodular | 2020 |
Inhibition of Colony-Stimulating Factor 1 Receptor by PLX3397 Prevents Amyloid Beta Pathology and Rescues Dopaminergic Signaling in Aging 5xFAD Mice.
Topics: Aging; Alzheimer Disease; Aminopyridines; Amyloid; Amyloid beta-Peptides; Animals; Brain; Disease Models, Animal; Dopamine; Dopaminergic Neurons; Hippocampus; Humans; Macrophage Colony-Stimulating Factor; Mice; Mice, Transgenic; Pyrroles; Receptors, Colony-Stimulating Factor; Signal Transduction | 2020 |
The effect of microglial ablation and mesenchymal stem cell transplantation on a cuprizone-induced demyelination model.
Topics: Aminopyridines; Animals; Behavior, Animal; Biomarkers; Calcium-Binding Proteins; Chemokine CX3CL1; Corpus Callosum; Cuprizone; CX3C Chemokine Receptor 1; Demyelinating Diseases; Disease Models, Animal; Glial Fibrillary Acidic Protein; Injections, Intraventricular; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Mice, Inbred C57BL; Microfilament Proteins; Microglia; Myelin Sheath; Pyrroles | 2021 |
Rescuing Over-activated Microglia Restores Cognitive Performance in Juvenile Animals of the Dp(16) Mouse Model of Down Syndrome.
Topics: Adult; Age Factors; Aminopyridines; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cognition; Disease Models, Animal; Down Syndrome; Female; Hippocampus; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microglia; Pyrroles | 2020 |
Sex- and region-biased depletion of microglia/macrophages attenuates CLN1 disease in mice.
Topics: Aminopyridines; Animals; Brain; Disease Models, Animal; Female; Macrophages; Male; Mice; Microglia; Nerve Degeneration; Neuronal Ceroid-Lipofuscinoses; Neurons; Pyrroles; Retina; Sex Factors; T-Lymphocytes; Tomography, Optical Coherence | 2020 |
Local Targeting of Lung-Tumor-Associated Macrophages with Pulmonary Delivery of a CSF-1R Inhibitor for the Treatment of Breast Cancer Lung Metastases.
Topics: Administration, Inhalation; Administration, Intravenous; Aminopyridines; Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Line, Tumor; Disease Models, Animal; Drug Screening Assays, Antitumor; Drug Synergism; Female; Humans; Lung Neoplasms; Mice; Paclitaxel; Phosphorylation; Pyrroles; Receptors, Granulocyte-Macrophage Colony-Stimulating Factor; Tumor Microenvironment; Tumor-Associated Macrophages | 2020 |
Long-term outcomes of pexidartinib in tenosynovial giant cell tumors.
Topics: Adult; Aged; Aged, 80 and over; Aminopyridines; Female; Giant Cell Tumor of Tendon Sheath; Humans; Male; Middle Aged; Pyrroles; Young Adult | 2021 |
Pexidartinib Long-Term Hepatic Safety Profile in Patients with Tenosynovial Giant Cell Tumors.
Topics: Aminopyridines; Chemical and Drug Induced Liver Injury; Giant Cell Tumor of Tendon Sheath; Humans; Liver; Pyrroles | 2021 |
Microglia Elimination Increases Neural Circuit Connectivity and Activity in Adult Mouse Cortex.
Topics: Aminopyridines; Animals; Female; Male; Mice; Microglia; Nerve Net; Photic Stimulation; Pyrroles; Receptors, Granulocyte-Macrophage Colony-Stimulating Factor; Visual Cortex | 2021 |
Microglial activation contributes to cognitive impairments in rotenone-induced mouse Parkinson's disease model.
Topics: Aminopyridines; Animals; Cognitive Dysfunction; Insecticides; Male; Mice; Mice, Inbred C57BL; Microglia; Minocycline; Parkinsonian Disorders; Pyrroles; Rotenone | 2021 |
A qualitative evaluation of patient and healthcare provider knowledge, attitudes, and behavior for safety and use of pexidartinib.
Topics: Aminopyridines; Health Knowledge, Attitudes, Practice; Health Personnel; Humans; Pyrroles | 2021 |
Microglia as target for anti-inflammatory approaches to prevent secondary brain injury after subarachnoid hemorrhage (SAH).
Topics: Aminopyridines; Animals; Anti-Inflammatory Agents; Brain Injuries; Ischemic Preconditioning; Mice; Mice, Inbred C57BL; Microglia; Pyrroles; Subarachnoid Hemorrhage | 2021 |
Pexidartinib treatment in Alexander disease model mice reduces macrophage numbers and increases glial fibrillary acidic protein levels, yet has minimal impact on other disease phenotypes.
Topics: Alexander Disease; Aminopyridines; Animals; Disease Models, Animal; Glial Fibrillary Acidic Protein; Macrophages; Mice; Mice, Inbred C57BL; Phenotype; Pyrroles | 2021 |
Brainstem local microglia induce whisker map plasticity in the thalamus after peripheral nerve injury.
Topics: Aminopyridines; Animals; Brain Stem; Female; Hypersensitivity; Male; Mice; Mice, Inbred C57BL; Microglia; Neurons; Peripheral Nerve Injuries; Pyrroles; Thalamus; Ventral Thalamic Nuclei; Vibrissae | 2021 |
The receptor of the colony-stimulating factor-1 (CSF-1R) is a novel prognostic factor and therapeutic target in follicular lymphoma.
Topics: Aminopyridines; Animals; Apoptosis; Biomarkers, Tumor; Cell Differentiation; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Lymphoma, Follicular; Macrophages; Mice; Monocytes; Phosphorylation; Pyrroles; Receptor, Macrophage Colony-Stimulating Factor; Tumor Cells, Cultured; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2021 |
Effect of CSF1R inhibitor on glial cells population and remyelination in the cuprizone model.
Topics: Aminopyridines; Animals; Cuprizone; Disease Models, Animal; Male; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Myelin Sheath; Neuroglia; Pyrroles; Receptor, Macrophage Colony-Stimulating Factor; Remyelination | 2021 |
Partial depletion and repopulation of microglia have different effects in the acute MPTP mouse model of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Aminopyridines; Animals; Behavior, Animal; Cyclooxygenase 2; Cytokines; Disease Models, Animal; Dopaminergic Neurons; Inflammation Mediators; Male; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Microglia; MPTP Poisoning; Neuroprotective Agents; Pyrroles; Receptors, Immunologic | 2021 |
A Phase I Study of the Combination of Pexidartinib and Sirolimus to Target Tumor-Associated Macrophages in Unresectable Sarcoma and Malignant Peripheral Nerve Sheath Tumors.
Topics: Aminopyridines; Humans; Male; Middle Aged; Neurofibrosarcoma; Pyrroles; Sarcoma; Sirolimus; Tumor-Associated Macrophages | 2021 |
Depletion of microglia mitigates cerebrovascular dysfunction in diet-induced obesity mice.
Topics: Aminopyridines; Animals; Basilar Artery; Cerebrovascular Disorders; Encephalitis; Male; Mice, Inbred C57BL; Microglia; Obesity; Pyrroles | 2021 |
Inhibition of CSF1R, a receptor involved in microglia viability, alters behavioral and molecular changes induced by cocaine.
Topics: Aminopyridines; Animals; Behavior, Animal; Brain; Chemokine CX3CL1; Cocaine; Cocaine-Related Disorders; Conditioning, Classical; Dopamine Uptake Inhibitors; Hippocampus; Inhibition, Psychological; Male; Mice; Microglia; Pyrroles; Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 2021 |
Microglia Depletion-Induced Remodeling of Extracellular Matrix and Excitatory Synapses in the Hippocampus of Adult Mice.
Topics: Aminopyridines; Animals; Brevican; CA1 Region, Hippocampal; CX3C Chemokine Receptor 1; Electrical Synapses; Excitatory Postsynaptic Potentials; Extracellular Matrix; gamma-Aminobutyric Acid; Green Fluorescent Proteins; Luminescent Proteins; Male; Mice, Transgenic; Microglia; Nerve Net; Pyrroles; Red Fluorescent Protein; Vesicular Glutamate Transport Protein 1 | 2021 |
PLX3397, a CSF1 receptor inhibitor, limits allotransplantation-induced vascular remodelling.
Topics: Aminopyridines; Animals; Macrophage Colony-Stimulating Factor; Mice; Protein Kinase Inhibitors; Pyrroles; Receptor Protein-Tyrosine Kinases; Vascular Remodeling | 2022 |
Exposure-response analysis of efficacy and safety for pexidartinib in patients with tenosynovial giant cell tumor.
Topics: Aminopyridines; Giant Cell Tumor of Tendon Sheath; Humans; Pyrroles; Response Evaluation Criteria in Solid Tumors | 2021 |
Tenosynovial giant cell tumor-diffuse type, treated with a novel colony-stimulating factor inhibitor, pexidartinib: initial experience with MRI findings in three patients.
Topics: Adult; Aminopyridines; Colony-Stimulating Factors; Giant Cell Tumor of Tendon Sheath; Humans; Magnetic Resonance Imaging; Pyrroles; Synovitis, Pigmented Villonodular | 2022 |
Myosin 1f-mediated activation of microglia contributes to the photoreceptor degeneration in a mouse model of retinal detachment.
Topics: Aminopyridines; Animals; Calcium-Binding Proteins; Cell Death; Cell Line; Disease Models, Animal; Gene Expression Profiling; Light; MAP Kinase Signaling System; Mice, Knockout; Microfilament Proteins; Microglia; Models, Biological; Myosin Type I; Myosins; Photoreceptor Cells, Vertebrate; Proto-Oncogene Proteins c-akt; Pyrroles; Retinal Degeneration; Retinal Detachment; Up-Regulation | 2021 |
Results from Phase I Extension Study Assessing Pexidartinib Treatment in Six Cohorts with Solid Tumors including TGCT, and Abnormal CSF1 Transcripts in TGCT.
Topics: Adult; Aminopyridines; Giant Cell Tumor of Tendon Sheath; Humans; Protein Kinase Inhibitors; Pyrroles | 2022 |
Quantification of the janus kinase 1 inhibitor upadacitinib in human plasma by LC-MS/MS.
Topics: Aminopyridines; Antirheumatic Agents; Arthritis, Rheumatoid; Chromatography, Liquid; Drug Monitoring; Heterocyclic Compounds, 3-Ring; Humans; Janus Kinase Inhibitors; Limit of Detection; Linear Models; Pyrroles; Reproducibility of Results; Tandem Mass Spectrometry | 2022 |
Sustained, complete response to pexidartinib in a patient with CSF1R-mutated Erdheim-Chester disease.
Topics: Aminopyridines; Cell Line; Erdheim-Chester Disease; Female; Humans; Mutation; Pyrroles; Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 2022 |
Eco-Friendly, Simple, Fast, and Sensitive UPLC-MS/MS Method for Determination of Pexidartinib in Plasma and Its Application to Metabolic Stability.
Topics: Aminopyridines; Antineoplastic Agents, Immunological; Chromatography, High Pressure Liquid; Drug Monitoring; Drug Stability; Molecular Structure; Protein Kinase Inhibitors; Pyrroles; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry | 2022 |
Microglial replacement in the aged brain restricts neuroinflammation following intracerebral hemorrhage.
Topics: Aging; Aminopyridines; Animals; Blood-Brain Barrier; Brain; Brain Injuries; Cell Death; Cerebral Hemorrhage; Chemotaxis, Leukocyte; Disease Models, Animal; Mice; Microglia; Neuroinflammatory Diseases; Pyrroles; Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 2022 |
Effect of Mild and Moderate Hepatic Impairment (Defined by Child-Pugh Classification and National Cancer Institute Organ Dysfunction Working Group Criteria) on Pexidartinib Pharmacokinetics.
Topics: Aminopyridines; Area Under Curve; Humans; Liver Diseases; Multiple Organ Failure; National Cancer Institute (U.S.); Neoplasms; Pyrroles; United States | 2022 |
Early posttraumatic CSF1R inhibition via PLX3397 leads to time- and sex-dependent effects on inflammation and neuronal maintenance after traumatic brain injury in mice.
Topics: Aminopyridines; Animals; Brain Injuries, Traumatic; Disease Models, Animal; Female; Inflammation; Macrophage Colony-Stimulating Factor; Male; Mice; Mice, Inbred C57BL; Microglia; Oxidoreductases; Pyrroles; Receptors, Colony-Stimulating Factor; Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 2022 |
CORR Insights®: Pexidartinib Provides Modest Pain Relief in Patients With Tenosynovial Giant Cell Tumor: Results From ENLIVEN.
Topics: Aminopyridines; Giant Cell Tumor of Tendon Sheath; Humans; Pain; Pyrroles | 2023 |